All for Statins and Statins for All; An Update

被引：21
作者：
Agouridis, Aris P. [1 ,2 ]
Elisaf, Moses S.
Nair, Devaki R. [2 ]
Mikhailidis, Dimitri P. [3 ]
机构：
[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
[2] Royal Free London Fdn Trust, Dept Clin Biochem, Vasc Dis Prevent Clin, London, England
[3] UCL, Dept Clin Biochem, Vasc Dis Prevent Clin, Sch Med, London NW3 2QG, England
来源：
CURRENT PHARMACEUTICAL DESIGN | 2016年 / 22卷 / 01期
关键词：
Statin; cardiovascular disease; cardiovascular risk factors; prevention; C-REACTIVE PROTEIN; INTIMA-MEDIA THICKNESS; DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-ARTERY-DISEASE; HIGH-DOSE ATORVASTATIN; RANDOMIZED CONTROLLED-TRIALS; LIPID-LOWERING THERAPY; CHRONIC KIDNEY-DISEASE; FIBRATE COMBINATION THERAPY; TRANSIENT ISCHEMIC ATTACK;
D O I：
10.2174/1381612822666151109111511
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Statins exert beneficial effects on cardiovascular [CV] outcomes as well as on inflammation and oxidative stress. The widespread use of statins for both primary and secondary CV disease prevention is based on the evidence from large randomized controlled trials. The benefits of statin treatment outweigh any harm in high risk patients. In this narrative review, we provide an update on several aspects of statin treatment based on the most recent evidence in this field.
引用
收藏
页码：18 / 27
页数：10
相关论文
共 184 条
[31]   Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia [J].
Bays, HE ;
Davidson, M ;
Jones, MR ;
Abby, SL .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (08) :1198-1205
[32]   Lifestyle Intervention and/or Statins for the Reduction of C-reactive Protein in Type 2 Diabetes: From the Look AHEAD Study [J].
Belalcazar, L. Maria ;
Haffner, Steven M. ;
Lang, Wei ;
Hoogeveen, Ron C. ;
Rushing, Julia ;
Schwenke, Dawn C. ;
Tracy, Russell P. ;
Pi-Sunyer, F. Xavier ;
Kriska, Andrea M. ;
Ballantyne, Christie M. .
OBESITY, 2013, 21 (05) :944-950
[33]   Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy [J].
Boden, William E. ;
Probstfield, Jeffrey L. ;
Anderson, Todd ;
Chaitman, Bernard R. ;
Desvignes-Nickens, Patrice ;
Koprowicz, Kent ;
McBride, Ruth ;
Teo, Koon ;
Weintraub, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24) :2255-2267
[34]   Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events A Meta-Analysis of Statin Trials [J].
Boekholdt, S. Matthijs ;
Hovingh, G. Kees ;
Mora, Samia ;
Arsenault, Benoit J. ;
Amarenco, Pierre ;
Pedersen, Terje R. ;
LaRosa, John C. ;
Waters, David D. ;
DeMicco, David A. ;
Simes, R. John ;
Keech, Antony C. ;
Colquhoun, David ;
Hitman, Graham A. ;
Betteridge, John ;
Clearfield, Michael B. ;
Downs, John R. ;
Colhoun, Helen M. ;
Gotto, Antonio M., Jr. ;
Ridker, Paul M. ;
Grundy, Scott M. ;
Kastelein, John J. P. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (05) :485-494
[35]   Pharmacogenetics and Statin Treatment: Reality or Theory? [J].
Bousoula, Eleni ;
Kolovou, Vana ;
Perrea, Despoina ;
Kolovou, Genovefa .
CURRENT VASCULAR PHARMACOLOGY, 2015, 13 (05) :616-623
[36]   The role of statins in erectile dysfunction: a systematic review and meta-analysis [J].
Cai, Xiang ;
Tian, Ye ;
Wu, Tao ;
Cao, Chen-Xi ;
Bu, Si-Yuan ;
Wang, Kun-Jie .
ASIAN JOURNAL OF ANDROLOGY, 2014, 16 (03) :461-466
[37]   Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[38]  
Chang Yu-Hung, 2013, Rev Diabet Stud, V10, P157, DOI 10.1900/RDS.2013.10.157
[39]   Safety and efficacy of statin treatment alone and in combination with fibrates in patients with dyslipidemia: a meta-analysis [J].
Choi, Hye Duck ;
Shin, Wan Gyoon .
CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (01) :1-10
[40]   Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].
Colhoun, HM ;
Betteridge, DJ ;
Durrington, PN ;
Hitman, GA ;
Neil, HAW ;
Livingstone, SJ ;
Thomason, MJ ;
Mackness, MI ;
Charlton-Menys, V ;
Fuller, JH .
LANCET, 2004, 364 (9435) :685-696
12345678910